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ABSTRACT 
EVIDENCE-BASED STRATEGIES TO MINIMIZE RISK FOR 
 
OPIOID PAIN MEDICATION MISUSE AMONG PATIENTS WITH  
 
CHRONIC PAIN IN A PRIMARY CARE SETTING 
 
by Carolyn Diane Coleman 
May 2015 
Background: Prescription opioid pain medication misuse has become a 
nationwide epidemic.  Many states have implemented prescription drug monitoring 
programs (PDMP) to assist in combating the problem of prescription opioid pain 
medication misuse.  Evidence-based clinical practice guidelines as well as the PMDP 
should be utilized by healthcare providers to guide treatment of chronic pain with opioid 
pain medications. Purpose: The purpose of this doctoral capstone project was to 
determine if providers are accessing the Prescription Drug Monitoring Program (PDMP) 
and utilizing evidence-based guidelines to minimize opioid pain medications misuse 
among patients with chronic pain in a primary care setting. Method: This project 
consisted of a retrospective chart review of prescribers’ documentation in the medical 
record to determine if the PDMP was accessed and if evidence-based protocols were used 
when prescribing opioid pain medication to patients diagnosed with chronic pain seen in 
a primary care clinic.  Results: Seven (N=7) records that met inclusion criteria for the 
project were identified for review over a three month time frame.  The seven records 
were all identified to have been seen by a nurse practitioner.  All (N=7; 100%) of the 
charts had a history and physical documented.  The PDMP was documented to be 
accessed on 5 of the 7 records (n=5; 71.4%).  Patients were prescribed an opioid pain 
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medication by the provider less than half (n=3; 42.9%) of the time.  Conclusion: This 
doctoral capstone project shows that the providers are documenting components of the 
history and physical when patients present to a primary care clinic with complaints of 
chronic pain. Past history of drug abuse and ordering urine drug screens are evidence-
based practice recommendations where prescribers have not documented consistently. 
Accessing the PDMP is another area where it shows the prescribers are not consistently 
documenting. Implementation of evidence-based guidelines will be imperative in the 
fight to minimize risk of misuse of opioid pain medications among patients with chronic 
pain in the primary care setting.  
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CHAPTER I 
INTRODUCTION 
 Prescription drug misuse is a growing problem in the primary care setting. The 
use of prescription drugs in a manner other than as directed is considered drug misuse. 
Drug abuse is the use of a prescription drug in a manner that deviates from the approved 
medical, legal, or social standards (Federation of State Medical Boards [FSMB], 2004).  
When prescription drugs are consumed in an excessive amount and injures the body, it is 
considered an overdose (FSMB, 2004).  According to the Centers for Disease Control 
and Prevention (CDC), deaths from prescription drug overdose have drastically risen over 
the past decade and have become the leading cause of death among the different types of 
overdoses in the United States (Centers for Disease Control and Prevention [CDC], 
2014).  With nearly 100 million Americans presenting with the complaints of chronic 
pain, according the Institute of Medicine (IOM), pain has become a public challenge 
(Institute of Medicine [IOM], 2011).  In a response to the 2001 Joint Commission’s 
standard on undertreated pain, opioid pain medications began to be prescribed to treat 
chronic pain (Broglio & Cole, 2014).  Many of these patients present to their primary 
care providers who may not have the proper training or tools for managing chronic pain 
(Broglio & Cole, 2014).  With the increase in opioid pain medication being prescribed for 
chronic pain came the misuse of the opioid pain medications (Broglio & Cole, 2014).  
Nearly 100 people died of drug overdoses from prescription drug misuse daily in the year 
2007, which shows a three-fold increase in the death rate from 1991.  (Paulozzi, Jones, 
Mack, & Rudd, 2011).  Prescription opioid pain medications contribute to prescription 
drug misuse because patients will sometimes take doses that are higher than what is 
needed in order to obtain a euphoric high (Worley, 2012). Prescription opioid pain 
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medications are also sold illegally to persons for whom the medication is not prescribed 
for purposes of getting a euphoric high (Worley, 2012). 
Opioid pain medications are controlled substances that are subject to special 
regulatory requirements under the federal Food and Drug Administration Controlled 
Substances Act of 1970 (FSMB, 2004).  Opioid pain medications are compounds that 
bind to an opioid receptor in the central nervous system and include medications such as 
hydrocodone, morphine, fentanyl, or oxycodone (FSMB, 2004).  The scheduling of 
controlled substances into classes V, IV, III, and II are special regulatory requirements 
for prescribing opioid pain medications (U.S. Food and Drug Administration [U.S. FDA], 
2009). The special regulatory requirements exist to prevent misuse and abuse of opioid 
pain medication prescriptions written for individuals by healthcare providers.  Providers 
may not have the proper training to manage chronic pain, when chronic pain is one of the 
most common reasons patients present to the primary care clinic (Liebschutz & Alford, 
2011).  Providers in primary care settings prescribe opioid pain medications for 
individuals with chronic pain.  Misuse of prescribed opioid pain medications is a concern 
in primary care settings, especially in the state of Mississippi (Dobbs, Byers, & Fleming, 
2013).  Many states in the U.S. have utilized Prescription Drug Monitoring Programs 
(PDMP) to address the issue of prescription drug misuse.  PDMP databases track 
controlled substance prescribing by healthcare providers and allow providers to track 
prescriptions for opioid pain medications filled by patients and report concerns to the 
appropriate law enforcement agencies (Fishman, 2012).  The PDMP was implemented to 
facilitate the collection, analysis, and reporting of information on the prescribing and 
dispensing of controlled substances (FSMB, 2004). 
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Although PDMP databases are not a complete solution to the prescription drug 
misuse problem, fully funding PDMP so they are real-time, interstate, and incorporated 
into the electronic health records (EHR) will identify patients that are doctor shopping 
and recognize potential prescription drug abusers (Drug Abuse, 2013). Doctor or 
prescriber shopping occurs when patients attempt to obtain controlled substances from 
multiple prescribers without the knowledge of the individual prescribers (CDC, 2014). 
Healthcare providers that are prescribers of opioid pain medications should utilize tools 
such as the PDMPs to identify drug misuse but also implement guidelines to assist with 
other methods of pain control when appropriate. Guidelines to steer patients toward 
alternative measures should be implemented as a start to combating the problem of 
misuse of opioid pain medications. Preventing misuse of prescription drugs by properly 
prescribing opioid pain medications for patients with a diagnosis of chronic pain may 
lead to improved health outcomes while maintaining proper pain control. As healthcare 
delivery moves towards patient-centered and outcomes-based care, combatting this 
growing problem of prescription drug misuse will be essential for maintaining wellness in  
patients with chronic pain that are seen in primary care settings in Mississippi 
Background and Significance 
   Prescription drug misuse. Prescription drug misuse has become a nationwide 
epidemic with deaths quadrupling since 1999 (CDC, 2011).  Emergency room visits due 
to prescription drug misuse have increased 114% in 2011, with 2.5 million emergency 
room visits as a result of drug misuse and 6,748 people treated in emergency departments 
daily for the misuse of drugs. Another 1.4 million are treated in emergency departments 
for prescription drug misuse (Highlights of DAWN report, 2011).  There were 458.3 
emergency room visits per 100,000 population due to the misuse of prescription drugs 
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with 134.8 visits per 100,000 population due to opioid pain medications in the year  2011 
(Highlights of DAWN, 2011).  The highest reported emergency room visits in 2011 for 
opioid pain medications misuse was due to the misuse of oxycodone (Highlights of 
DAWN, 2011). 
 Adults and teens in community counties as well as soldiers and veterans who 
survive serious injuries are at higher risk of misusing prescription drugs and overdosing 
(Mississippi State Department of Health [MSDH], 2014).  The elderly population 
accounts for approximately one quarter of prescription drugs sold in the Unites States 
yearly (Culberson & Ziska, 2008);   however, it is difficult to estimate the prevalence of 
prescription drug misuse among the elderly population. It has been determined that up to 
eleven percent of older women misuse and/or abuse prescription drugs (Culberson & 
Ziska, 2008).  The elderly are more prone to have complaints of chronic pain, insomnia, 
and anxiety leading to being treated with prescription drugs.  It is also noted that misuse 
of prescription pain medication in occupational injuries is becoming an epidemic in 
worker’s compensation cases in the state of Mississippi (MSDH, 2014). 
Prescription drug overdose and death.  An estimated 71,000 children under the 
age of 18 years visited an emergency room as a result of prescription medication 
overdose between 2004 and 2005 (CDC, 2014).  The lowest death rates in the United 
States were among children less than 15 years of age due to the fact there are less 
incidents of prescription drug use among this age group (CDC, 2014). It is also reported 
that 40% of calls reported to the poison centers between 2004 and 2005 for children 
under the age of six are related to prescription drug overdose (CDC, 2014). One hundred 
and fourteen people died daily in 2011 in the United States as a result of drug overdose 
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(Centers for Disease Control and Prevention [CDC], 2014). According to the Centers for 
Disease Control and Prevention, deaths from prescription drug overdose have surpassed 
traffic-related deaths in 2009 as the leading cause of death in the United States (CDC, 
2014).  The age of highest death rates for prescription drug misuse in the United States lie 
between 45 and 49 years of age and occur among American Indians/Alaska Native, 
followed by whites then blacks (CDC, 2014).  While these are alarming national statistics 
on drug overdose and death, the death rate from the misuse of prescription opioid pain 
medications is mainly related to unintentional overdoses of these prescription opioids.  
This project will focus on the problem of opioid pain medication misuse among patients 
with chronic pain in primary care settings in Mississippi.  
Prescription drug misuse, overdose, and deaths in Mississippi   
The number of prescription drug overdose deaths in Mississippi, tripled from 
1999 to 2013 (Drug Abuse, 2013).  Mississippi has the 30th highest prescription drug 
overdose mortality rate in the United States, with 11.4 per 100,000 fatalities (Drug abuse, 
2013). The number of deaths from unintentional prescription drug overdose in the state of 
Mississippi has increased 10-fold since 1990 (MSDH, 2013).  The number of deaths have 
increased from 23 in 2009 to 232 in 2011(MSDH, 2013).  The number of unintentional 
prescription drug overdoses have consistently remained the highest in the 45-54 year old 
age group in the state of Mississippi (MSDH, 2013).Prescription drug misuse accounted 
for 90% of the overdose deaths in Mississippi in 2012, mostly accidental (MSDH, 2014).  
While these statistics from various sources using diverse time spans may appear to be 
different, the overall message is that the misuse of prescription opioid pain medication 
has reached epidemic levels.  
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In community health primary care clinics in Mississippi, the misuse of 
prescription opioid pain medication is attributed to a ten-fold increase in death (Dobbs, et 
al. 2013).  In the month of January 2013, there were approximately 180,000 individual 
prescriptions for hydrocodone products prescribed in Mississippi with over 10 million 
unit doses or pills dispensed (MSDH, 2013).  In the state of Mississippi, this large 
number of pills would be sufficient to dose every man, woman, and child in the state 
more than three doses of hydrocodone during that month (MSDH, 2013).  In a response 
to the increasing number of prescription controlled substances the state of Mississippi has 
implemented a web-based prescription drug monitoring program to monitor the 
prescribing and dispensing of controlled substances, such as the opioid pain medications. 
Prescription drug monitoring programs.  Many states have utilized prescription 
drug monitoring programs (PDMP) to address the issue of prescription drug misuse and 
state laws have also been implemented to help combat the increasing epidemic of 
prescription drug misuse. States have adopted laws such as requiring ID or permitting the 
pharmacy to require an ID prior to dispensing controlled substances, expansion for 
coverage of substance abuse programs, mandatory usage of prescription drug monitoring 
programs by prescribers, and Good Samaritan Laws which give immunity or mitigation 
of sentencing to persons seeking help for themselves (Drug abuse, 2013).  These laws all 
serve as an attempt to decrease mortality rates, decrease the number of individuals who 
misuse prescription medications, and deter doctor shopping.   
 In the state of Mississippi, the PDMP report alerts the prescriber to possible 
prescription drug misuse.  The PDMP, web-based tool was designed to comply with the 
National All Schedules Prescription Electronic Reporting Act of 2005 and is managed 
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through the Board of Pharmacy in the state of Mississippi (Dobbs et al., 2013).  The 
PDMP tracks the number of dosage units, the different providers who have prescribed 
opioids to certain patients, and the pharmacies where the patients have had their 
prescriptions filled (Dobbs et al., 2013).  The Board of Medical Licensure changed its 
Administrative code to require all prescribing physicians and physician assistants to be 
registered with the PDMP by December 31, 2013 (Dobbs et al., 2013).  The MBOML 
changes also require educational hours to be completed every two years related to 
prescribing, with an emphasis on controlled substances (Dobbs et al., 2013).  According 
to the positions statement posted to the MS Board of Nursing’s website as of December 
2014 the board will require all advanced practice nurses to be registered with the Board 
of Pharmacy’s PDMP and recommends usage when prescribing controlled substances 
(Mississippi Board of Nursing [MSBN], 2014).  Other changes have been implemented to 
deter prescription opioid drug abuse.  As of October 2014 hydrocodone has been moved 
from a scheduled III to schedule II making prescribing excessive amounts less likely and 
restricting refills (Dobbs et al., 2013). 
Although laws vary widely from state to state, the state of Mississippi scored five 
out of ten on the New Policy Report Card of Promising Strategies to Help Curb 
Prescription Drug Abuse (Drug abuse, 2013).  Mississippi’s regulatory boards have 
implemented state regulations that require all prescribers to register with the Board of 
Pharmacy’s PDMP.  According to the MS State Statues 73-21-127, 73-21-97, and 73-21-
103, Mississippi has implemented guidelines for PDMP and has an active program 
running ("Cumulative supplement to MS code," 2007).  Mississippi has also implemented 
doctor shopping laws that specify that patients are prohibited from withholding 
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information about prior prescriptions from their healthcare providers (Dobbs et al., 2013).  
Mississippi also has pharmacy lock-in programs which require patients under the state’s 
Medicaid program who are suspected of misusing controlled substances to use a single 
prescriber and pharmacy to obtain medications (Dobbs et al., 2013).  And lastly, 
Mississippi requires or recommends continuing education hours for providers prescribing 
opioids (Dobbs et al., 2013).  There are also guidelines requiring healthcare providers to 
physically examine patients or have a bona fide patient-physician relationship before 
prescribing a controlled substance.  These steps should be followed when encountering 
patients that present to the primary care clinic with complaints of chronic pain.  
Accessing the PDMP prior to prescribing prescription opioid pain medications 
should alert a prescriber to opioid pain medications that have been obtained from other 
prescribers.  This project will look at the usage of the PDMP along with evidence-based 
practice guidelines for treatment of chronic pain by prescribers in an attempt to minimize 
prescription opioid pain medication misuse in a primary care clinic in the state of 
Mississippi. 
Chronic pain. According to the Institute for Clinical Systems Improvement, 
chronic pain is defined as pain without biological value that has persisted beyond the 
normal time despite the usual customary efforts to diagnose and treat the original 
condition and injury (Hooten et al., 2013).  Chronic pain affects at least 116 million 
adults in the United States and up to $635 billion each year is spent on medical cost and 
lost productivity due to chronic pain (Hooten et al., 2013).  In the primary care setting 
approximately 5-33% of the patients present with a complaint of chronic pain (Hooten et 
al., 2013).  Patients with chronic pain present to the primary care clinic with complaints 
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of low back pain, headaches, neck pain, and fibromyalgia (Hooten et al., 2013).  
Evidence-based clinical practice (EBCP) guidelines for treatment of chronic pain require 
prescribers to take a full history and physical and assess functioning when patients 
present to the primary care clinic with complaints of pain.  EBCP guidelines for treating 
pain state the goals for treating pain should include more than prescribing  prescription 
pain medications, but also measures to improve the patient’s functioning ability (Hooten 
et al., 2013). 
Prescription pain medication.  Opioid pain medications are a class of medications 
used to treat chronic pain. The mechanism of action for opioid pain medications is the 
opioid compound binds to opioid receptors in the nervous system causing depression of 
the nervous system and skeletal muscle relaxations (FSMB, 2004).  Adverse effects of 
opioid pain medications are nausea, vomiting, sedation, cognitive impairments 
respiratory depression, and even death (FSMB, 2004).  In addition, opioids have 
addiction-forming or addition sustaining liability or are capable of conversion into a drug 
having such addiction-forming or addition-sustaining liability (U.S. FDA, 2009).   
 Indirect and direct healthcare costs related to opioid pain medications are related 
to misuse, abuse, addiction, dependence, overdose, and death.  In a research of claims 
data and other publicly available surveys and secondary sources, Birnbaum et.al looked at 
the costs to society of opioid abuse, dependency, and misuse in the United States 
(Birnbaum et al., 2011).  Costs were grouped in three categories: healthcare, workplace, 
and criminal justice (Birnbaum et al., 2011).  Workplace costs were approximately $25.6 
billion or 46% of the total cost and were driven by lost earnings and reduced 
compensations (Birnbaum et al., 2011).  Healthcare costs were approximately $25.0 
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billion or 45% of the total costs and consisted of medical and prescription costs 
(Birnbaum et al., 2011).  With criminal costs consisting of $5.1 billion or 9% of the total 
costs and were comprised of correctional facility and police costs (Birnbaum et al., 2011).  
Data were obtained from private insurance as well as Medicaid claims data. The study 
concluded that prescription drug misuse bears a large financial burden on society and as 
the prevalence increase the societal economic burdens will also increase (Birnbaum et al., 
2011).  The changes to healthcare in the Affordable Care Act, providing efficient, cost 
effective care will be crucial factors in the primary care setting.  Reimbursement will be 
associated with patient outcomes and the quality of care provided.  
Properly prescribing treatments for pain control improves delivery of healthcare 
and outcomes for patients with chronic pain. Increasing education of healthcare providers 
should ensure that providers properly prescribe prescription opioid pain medications and 
give prescribers a better understanding of how prescription opioid pain medications can 
be misused (Drug Abuse, 2013).  Accessing the PDMP allows prescribers to be informed 
on prescriber-shopping behaviors in patients with complaints of chronic pain and allow 
prescribers to make proper decisions when prescribing treatments for pain control.  As 
patients present to the primary care settings with complaint of chronic pain, prescribers 
should be utilizing evidence-based practice guidelines as well as the PMDP to guide 
treatment of chronic pain.  
Deaths from prescription opioid pain medication misuse have steadily increased 
over the past decade.  Many states have implemented prescription drug monitoring 
programs to assist in combating the problem of prescription drug misuse.  Prescribers in 
the primary care health care clinic include physicians and nurse practitioners. Nurse 
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practitioners that are prepared with a practice focused doctorate degree, the Doctor of 
Nursing Practice (DNP), are prepared to lead change in practice setting through 
organizational and systems leadership for quality improvement. Using the Plan Do Study 
Act (PDSA) model for quality improvements, this capstone project will show continuous 
improvements in the quality of patient outcomes while minimizing the risk of 
prescription drug misuse. Evaluating and implementing evidenced-based protocols to 
minimize the risk of prescription opioid pain medications is within the scope of practice 
of a DNP prepared nurse practitioner.  This capstone project conducted by a family nurse 
practitioner (FNP) in a DNP program will focus on providers in a primary  health clinic 
in the state of Mississippi and  determine if the providers are utilizing EBCP guidelines 
including accessing the PDMP to minimize the risk of opioid pain medication misuse by 
patients with a  diagnosis of chronic pain.   
Needs Assessment 
While working as a FNP in a community based primary care setting in central 
Mississippi, several patients presented to the clinic with complaints of chronic pain 
requesting prescriptions for opioid pain medications.  A survey of providers, physicians 
and nurse practitioners, revealed similar experiences with no clear directions on 
prescribing of opioid pain medications, leaving prescribers to rely on clinical judgments 
and past experiences.  Although the state of Mississippi has an active PDMP, most 
providers at the clinic were not registered with the PDMP, or if registered, were not 
accessing the reports.  There were also no clear evidence-based guidelines for prescribing 
opioid pain medication in the clinic; therefore, prescriber were left to use their clinical 
knowledge and expertise.  
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Further evaluation included reviewing, over a 12 month period, medical records 
of patients who presented to the clinic with reports of chronic pain using diagnosis codes 
338.2 (chronic pain), 338.21 (chronic pain due to trauma), and 338.29 (other chronic 
pain) who received a prescription from a provider for opioid pain medication. The 12 
month review revealed 125 patients who had a diagnosis of chronic pain and were 
prescribed an opioid pain medication.  Of the patients with a diagnosis of chronic pain the 
distribution of males and females were essentially equal (n=62 males; 49.6% and n=63 
females; 50.4 %).  Forty-two or approximately 34% of the patients were between the ages 
of 45-54 years of age.  The results of the medical review  was presented to the key 
stakeholders of the organization who agreed to proceed with the implementation of 
educating the providers on using  evidenced-based protocols to treat patients with chronic 
pain seen in the primary care  clinic to minimize the risk of prescription opioid pain 
medication misuse.  As a DNP student and full-time prescriber in the clinic, 
implementing the evidence-based protocols would improve the quality of patient 
outcomes in the clinic. While providing education on EBCP guidelines for prescribing 
opioid pain medications for chronic pain, prescribers’ attitudes toward using the PDMP 
were explored and barriers to use were identified.  Steps to alleviate the barriers to 
accessing the PDMP were put in place.  The results of the educational intervention were 
presented to the medical director and approval was obtained to determine providers’ use 
of the PDMP and the impact of accessing the PDMP on proper prescribing of opioids. 
The problem.  As patients seek care in primary care settings with complaints of 
chronic pain, healthcare providers’ first thoughts are to treat the patient with a 
prescription for an opioid pain medication.  Sometimes this will lead to repeat offenders 
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returning multiple times with similar or the same complaints looking for continued 
prescription refills of opioid pain medication.  Every effort should be made to find 
alternative treatments, especially when patterns are noted.  A comprehensive history 
including accessing the PDMP should be taken and a complete physical examination 
should be conducted to ensure proper prescribing.  It is important that patients receive 
pain-relieving medications when needed, with proper dosing (beginning with the lowest 
dose and titrating for pain relief) and quantities (Fishman, 2012). 
The DNP prepared nurse practitioner should be ready to take on the problem-of 
prescription drug misuse and work with others in the health care arena to devise 
solutions, formulate plans and guidelines, and come to the table to have changes 
implemented. Once a systematic review of the literature is conducted, evidence-based 
guidelines can be implemented to improve patient and system outcomes. For this DNP 
project, the PICOT question to be addressed was: In patients that present to a primary 
care clinic with a diagnosis of chronic pain and request prescriptions for opioid pain 
medications, how does accessing the PDMP and utilizing evidence-based guidelines prior 
to prescribing treatment compared to not using the PDMP and evidence-base guidelines 
minimize the risk of opioid misuse?  
Relevant Review of the Literature 
 Data sources accessed for this study include the following databases: CINAHL, 
Cochrane Database, MEDLINE, PsycARTICLES, PsychINFO and evidence-based 
treatment guidelines. Key terms used in the review of the literature were: opioid pain 
medication, PDMP, chronic pain, provider prescribing habits, evidence-based guidelines, 
mitigation strategies  
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Prescription drug monitoring programs. In a systematic literature review of 
eleven peer reviewed research articles, an investigation of Prescription Drug Monitoring 
Programs (PDMPs) use, implications to practice, and barriers were explored (Worley, 
2012).  In this study eleven peer reviewed research articles were identified and reviewed. 
The researcher identified four themes: PDMPs effect on prescribing opioids, PDMPs 
effects on prescribing benzodiazepines, multiple provider use and patient characteristics, 
and healthcare professional’s perspectives on PDMPs (Worley, 2012).  On conclusion of 
the review it was noted that are few research studies done on this subject (Worley, 2012).  
It was confirmed that the use of PDMPs limits doctor shopping and reduces prescription 
drug misuse (Worley, 2012). Further research is needed to determine the frequency that 
prescribers use PDMPs, barriers to its use, and what interventions would increase usage 
of PDMPs (Worley, 2012). 
In a study performed by Reigler et.al, the question was asked whether prescription 
drug monitoring programs impact opioid misuse. In this observational study data from a 
poison center and an opioid treatment center were used to observe whether there were 
changes in the surveillance data after implementation of a prescription monitoring 
program (Reigler et al., 2012).  The result of the study showed PDMPs are effective in 
decreasing prescription opioid misuse (Reigler et al., 2012).  The data showed the 
increase of intentional exposures and also the increase of admissions to treatment centers 
to be much lower in states where PDMPs had been implemented (Reigler et al., 2012). 
In a briefing on PDMP performed by the PDMP Center of Excellence at Brandeis 
University, concluded that the use of PDMPs are effective in improving clinical decision 
making and improved patient outcomes ("Briefing on PDMP," 2014).  The revised 
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version of the briefing contained over 60 references that includes research studies, 
evaluations, surveys, reports, and data to support these conclusions ("Briefing on 
PDMP," 2014).  The briefing also states that the PDMP will become more effective as 
prescribers continue to use evidence-based best practices ("Briefing on PDMP," 2014). 
Treatment modalities for chronic pain.  The Institute for Clinical Systems 
Improvement (ICSI) provided recommendations for improved treatments for patients 
with complaints of chronic pain (Hooten et al., 2013).  According to the 
recommendations it is important to look at the problem of prescription drug misuse from 
a clinical as well as an operational viewpoint (Hooten et al., 2013).  Processes should be 
developed to allow patients to see dedicated prescribers who should work collaboratively 
with other healthcare providers, such as dentists and specialists to coordinate care 
(Hooten et al., 2013).  Policies should be implemented to monitor and maintain opioid 
agreements prior to prescribing an opioid pain medication (Hooten et al., 2013).  
Education to prescribers for referring patients to other disciplines such as pain 
management clinic should be implemented (Hooten et al., 2013).  According to the ICSI 
chronic care teams that include prescribers, pharmacy, behavioral health, physical 
therapy, and pain management should also be implemented when treating patients with 
complaints of chronic pain (Hooten et al., 2013).  While patients should have a pain 
assessment conducted prior to providing treatment for pain relief, the goal of treatment 
should be the improvement of overall functioning, not simply to give pain medication 
(Hooten et al., 2013).  Examples of tools to assess for pain and functioning may include 
the Brief Pain Inventory (BPI) or the Physical Functional Ability Questionnaire (FAQ5) 
(Hooten et al., 2013). 
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Prescription drug misuse and abuse recognition.  Obtaining a good history and 
physical is one of the major determinants of risk for misuse of opioid pain medications 
(FSMB, 2004; “Guidelines for prescribing opioids”, n.d.).  Obtaining the history and 
physical can clue a prescriber into past history of misuse. The history should include a 
past medical, family/social and past medical history including history of mental health 
problems and substance abuse. (“Guidelines for prescribing opioids”, n.d.).  Assessing 
the nature and intensity of pain, assessing the effect of pain on daily functioning and 
quality of personal life, also assessing the past history of opioid use are all areas to alert a 
prescriber into clues for possible risk of misuse (Fishman, 2012).  Any comorbid 
conditions should be identified as well as psychological and mental health histories 
(Fishman, 2012).  Obtaining the complete and thorough history and physical could lead 
to improved identification of patients at risk for prescription opioid pain medication 
misuse.  
Culberson and Ziska (2008) studied the misuse of prescription drugs in the elderly 
by reviewing the literature of studies previously reported.  Unsafe amounts of 
medications obtained by older adults are usually not obtained for the reasons of “getting 
high”, but instead by seeking prescriptions from multiple physicians or doctor shopping, 
by stockpiling medications over a period of time, (Culberson & Ziska, 2008).  Therefore 
prescription drug abuse for the elderly is different than for younger persons (Culberson & 
Ziska, 2008). According to Culberson and Ziska (2008) there is not a validated screening 
instrument designed to identify or assess for prescription drug abuse in the elderly.  
Although they did look at the Severity of Dependence Scale for use as a screening 
instrument for benzodiazepine dependence when looking at elderly patients who use 
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benzodiazepines (Culberson & Ziska, 2008).  Elderly patients with symptoms such as 
anxiety, pain, and insomnia are at risk for prescription drug abuse, although illicit drug 
use is rare among the elderly (Culberson & Ziska, 2008).  Other causes of misuse/abuse 
can be contributed to inappropriate prescribing or poor monitoring by health care 
professionals (Culberson & Ziska, 2008).  It is generally uncommon for prescription drug 
abuse among elderly patients who have no history of substance abuse problems 
(Culberson & Ziska, 2008).  This study of 565 geriatric psychiatric patients concluded 
that elderly individuals with social isolation, depression, and history of substance abuse 
are at increased risk of prescription drug abuse (Culberson & Ziska, 2008).  It also notes 
that the development and validation of screening instruments and treatment guidelines for 
prescription drug abuse in the elderly may aid in the appropriate use of prescription 
medications (Culberson & Ziska, 2008). 
Prescribing opioid pain medication. In a cohort study by Dunn et al., pharmacy 
data were obtained and medical records were reviewed and analyzed to study estimated 
rates of opioid overdose. This study sought persons who received 3 or more opioid 
prescription for noncancerous pain within a ninety day period (Dunn et al., 2010).  The 
authors selected 9940 people who started long-term opioid therapy and followed them for 
forty-two weeks (Dunn et al., 2010). Of those who were selected in the study, 61% of the 
participants completed the study, 32% left during the study, and 7% died (Dunn et al., 
2010). There were six fatal opioid-related overdoses and 74 non-fatal overdoses during 
the study (Dunn et al., 2010). Dunn et al. found the overdose rate for persons 65 years 
and older was greater than the overdose rate of younger adults (Dunn et al., 2010). The 
results of the study showed patients receiving higher doses of prescription opioid 
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medications in higher doses were at a higher risk of overdosing than persons receiving a 
lower dosage (Dunn et al., 2010).  Although there were limitations to the study it could 
not be established whether overdose risk differences were directly related to dosages or 
patient characteristics (Dunn et al., 2010).  Dunn et al. states further studies are needed to 
understand the specific determinants of overdose risk in patients receiving long-term 
opioid therapy (Dunn et al., 2010).  It also suggests that persons receiving long-term 
opioid therapy should be closely monitored and careful instructions on appropriate use of 
medications (Dunn et al., 2010).  
The Centers for Disease Control and Prevention, the National Center for Injury 
Prevention and Control, along with the National Institute on Drug Abuse (NIDA) and the 
Substance Abuse and Mental Health Services Administration (SAMHS), and the Office 
of the National Coordinator for Health Information Technology (ONC), together 
reviewed and compared eight guidelines to identify common areas for recommendations 
for prescribing opioids for chronic pain (CDC, n.d.).  Common elements found in all 
eight guidelines include:  
• Conducting a physical exam, pain history, past medical history, and 
family/social history 
• Conducting urine drug testing 
• Considering all treatment options, weighing the risks and benefits of 
prescribing opioids 
• Starting patients on the lowest effective dose 
• Implementing pain treatment agreements 
• Monitoring pain and treatment progress with documentation 
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• Using safe and effective methods for discontinuing opioids (CDC, n.d., 
para. 6). 
In a systematic review by Nuckols et al. (2014), guidelines were screened for 
prescribing opioids utilizing an appraisal of 1132 unique records.  Recommendations 
from 13 guidelines were abstracted assessing dosing limits, medications and 
formulations, titration of dose, switching from one opioid to another, drug-to-drug 
interactions, and risk mitigation strategies (opioid risk assessment tools, written treatment 
agreements, and urine drug testing).  Thirteen guidelines on using opioids to treat chronic 
pain were evaluated for quality related to mitigating risks for overdose and misuse 
(Nuckols et al., 2014).  Although the guidelines were derived from various clinical 
emphasis and backgrounds, common themes emerged from the evaluation (Nuckols et al., 
2014).  The guidelines generally agreed on the following issues:  need for caution in 
prescribing doses greater than 90 to 200 mg of morphine equivalents per day, having 
knowledgeable clinicians when managing methadone, recognizing risks associated with 
fentanyl patches, titrating with caution, and reducing doses by 25-50% when switching 
from one opioid to another (Nuckols et al., 2014).   
Guidelines for prescribing opioids established by the Federation of State Medical 
Boards (FSMB) state a medical history and physical must be obtained, evaluated, and 
documented in the medical record when prescribing opioids (FSMB, 2004).  The 
guidelines state there should be a written treatment plan with objectives to determine 
treatment success, such as improved physical functioning (FSMB, 2004). Once opioids 
are prescribed, the prescriber should adjust drug therapy to each patient’s individual 
needs, which could include other treatment modalities such as a rehabilitation program 
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(FSMB, 2004). The prescriber should periodically review the patient’s treatment plans 
and their progress towards the objectives and modify treatment as needed (FSMB, 2004).  
If progress is unsatisfactory, the prescriber should assess the appropriateness of the 
current treatment plan and consider other therapeutic modalities (FSMB, 2004).  
Prescribers should be willing to refer patients for additional evaluations and treatments 
for the management of their chronic pain (FSMB, 2004).  The medical record should 
include the following:  
• Medical history and physical 
• Diagnostic, therapeutic, and laboratory results 
• Evaluations and consultations 
• Treatment objectives 
• Discussion of risks and benefits 
• Informed consent 
• Treatments 
• Medications 
• Instructions and agreements, and 
• Periodic reviews. (FSMB, 2004) 
Risk mitigation strategies. Risk mitigation strategies should be implemented when 
prescribing opioid pain medications.   Risk assessment tools should be used, written 
treatment agreements should be obtained, and urine drug testing would be helpful when 
prescribing opioids (FSMB, 2004; Nuckols et al., 2014).  The Screener and Opioid 
Assessment for Patients with Pain (SOAPP) is a tool used by prescribers to help 
determine a patient’s risk for long-term opioid use ("SOAPP," 2008).  The SOAPP is a 
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questionnaire developed to assist prescribers in evaluating patients for relative risk of 
developing problems from long-term opioid use ("SOAPP," 2008).  Patients can be 
categorized into three different groups based on their SOAPP scores (low, medium, or 
high) showing their relative risk for problems when being prescribed opioid pain 
medications ("SOAPP," 2008).  It is also noted that the SOAPP is a tool to assess the risk 
of opioid pain medication misuse and not a lie detector and there may be false positives 
("SOAPP," 2008). Other tools that assess for risk include the CAGE, Current Opioid 
Misuse Measure (COMM), Screening Tool for Addiction Risk (STAR), and Webster’s 
Opioid Risk Tool (ORT).  
  Informed consent and agreement for treatment should be obtained by the 
prescriber with the risks and benefits of the use of opioid medications discussed with the 
patient and/or the patient’s family (FSMB, 2004).  Patients who are a high risk for misuse 
should have a written agreement with the provider outlining the patient’s responsibilities 
which may include drug screening when requested, number and frequency of all 
prescription refills, and reasons for which drug therapy may be discontinued (FSMB, 
2004; “Guidelines for prescribing opioids,” n.d., para. 6) 
In summary the review of literature shows us that the PDMP and implementing 
evidence-based guidelines are effective in minimizing the risk for prescription opioid 
pain medication misuse. Prescribers should obtain thorough history and physicals to 
assess the patients’ risk for misuse of opioid pain medications.  To assist in assessing for 
risk, the literature provides risk assessment tools such as the SOAPP or COMM that 
should be used in combination with other evidence-based guidelines.  The literature 
suggest that inappropriate prescribing contributes to the increasing misuse of prescription 
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opioid pain medications  The literature shows that care coordination is another area that is 
key in minimizing misuse of opioid pain medications. Prescribers should be willing to 
make appropriate referrals to other providers such as physical therapy and mental health 
providers when patients present to the primary health clinic with complaints of chronic 
pain.  This project will evaluate whether implementing evidence-based guidelines, as 
shown in the literature review (Appendix A), by providers minimizes the risk for 
prescription opioid pain medication misuse among patients with chronic pain in a primary 
care setting.  
Framework (Theoretical Background) 
This project will utilize a portion of Deming’s 14 point model to guide the study. 
The ability to use statistics to aide in the discovery of root causes to problems, and also to 
create solutions to manage corrective measures are at the heart of Deming’s 14 points of 
management.  Deming’s theory creates the consistency for improvement of products and 
services. The point utilized for this project refers to constantly and forever improve the 
system of production and service ("The Fourteen Points for Management," 2015). 
Deming proposed a continuous loop of identifying a problem, changing the process, and 
re-assessing processes for continuous quality improvements ("The Fourteen Points for 
Management," 2015).  
As a framework, this project will use the Plan-Do-Study-Act to show the 
continuous cycle of quality improvements.  The “Plan” is to evaluate whether prescribers 
are utilizing evidence-based guidelines which include assessing the PDMP prior to 
prescribing opioid pain medication.  The “Do” consists of the education of the providers 
on prescription opioid drug misuse, the importance of using  evidence-based guidelines 
which include the PDMP when prescribing opioids, ensuring they are all signed up for 
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the PDMP.  “Study” is the evaluation of whether prescribers are utilizing evidence-based 
guidelines prior to prescribing opioid pain medication, and “Act” is an evaluation for 
further needs and the cycle starts over.  
DNP Essentials 
 On completion of this capstone project, the DNP essentials are fully met and 
listed in Appendix B (American Association of Colleges of Nursing [AACN], 2006).  By 
using evidence-based protocols to implement a change in the prescribing practices of 
providers in a primary care community health center, the project seeks to minimize the 
risk of misuse of opioid pain medications in patients with the diagnosis of chronic pain. 
The use of EMR to access medical records for data gives knowledge of information 
systems and technology which is essential for the DNP prepared advanced practice nurse. 
Development of the project gave knowledge in organizational and systems leadership by 
allowing the evidence-based protocols to be introduced to the community health clinic’s 
staff and leadership. Introducing the providers to evidence-based healthcare policy 
improves patient outcomes in the primary care setting and allows the DNP prepared 
advanced practice nurse to develop strategies to enhance and evaluate healthcare 
outcomes.  Implementing the quality improvement project shows expertise in assessing 
and identifying organizational and systems issues and facilitates organization-wide 
changes in prescribing habits.  Collaborating with key stakeholders and other providers in 
the clinic to minimize the risk of prescription opioid pain medications aides in improving 
patient outcomes.  The results of this project will first be submitted to the organization for 
quality improvements, then possibly other clinics to improve population health.   
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Evaluation Plan 
This project seeks to evaluate whether evidence based guidelines including the 
Prescription Drug Monitoring Program (PDMP) are utilized by healthcare providers prior 
to prescribing opioid pain medications in patients diagnosed with chronic pain.  The 
Logic Model in Appendix C demonstrates the evaluation plans for this project.  
Assumptions. The assumption is that once educated providers will change their 
current prescribing habits and adopt more evidence-based practices.  It is also assumed 
that once these guidelines are followed the risk of patients misusing prescription opioids 
would be minimized by prescribers obtaining thorough history and physicals, obtaining 
informed consent, urine drug screens, and also accessing the PDMP.  
Purpose of the project. The purpose of this doctoral capstone project is to 
determine if providers are accessing the PDMP and utilizing evidence-based guidelines to 
minimize opioid pain medication misuse among patients with chronic pain in a primary 
care setting.  
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CHAPTER II 
METHODS 
The purposes of this doctoral capstone project is to determine if  healthcare  
providers are accessing the PDMP and utilizing evidence-based guidelines to minimize 
opioid pain medication misuse among patients with chronic pain in a primary care 
setting.  The project was implemented after receiving approval from the Institutional 
Review Board (IRB) at the University of Southern Mississippi (Appendix D). 
Setting 
 The capstone project was conducted in a primary care clinic which serves patients 
across the lifespan, from infants to older adults.  This clinic is located in an urban 
metropolitan area in central Mississippi and serves patients with all types of health 
insurance, but a majority of the patients are covered under Medicare and Medicaid. 
Uninsured patients are also seen and billed for healthcare services according to a sliding 
scale payment plan. This clinic is a Federally Qualified Health Clinic which exists to 
provide healthcare to underserved populations.  The patient base consists of 
approximately 60% females and 40% males.  The racial/ethnic make up for the 
population of this community health clinic-up consists of 94% African Americans, 5% 
Caucasians, and 1% Hispanic or other.  
There are a total of 45 full-time employees and 2 part-time contract employees.  
Of the 47 employees, the clinic employs a total of 13 providers that can prescribe 
medications: 4 full-time and 1 contract nurse practitioners (NP); 1 full-time physician 
assistant (PA); and 5 full-time physicians and 1 contract physician (Doctor of Medicine 
[MD], and 1 Doctor of Osteopathy [DO]) .  There are three different clinic locations that 
fall under this one community health primary care clinic. Data from the EMR will be 
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collected from all three locations.  A letter of support from the organization has been 
obtained prior to implementing the project (Appendix E) 
Population 
 The subjects for this project comprise a convenience sample of healthcare 
providers, (physicians, nurse practitioners, and physician assistants) who prescribe an 
opioid pain medication and provide healthcare to patients between the ages of 45 thru 54 
years of age who have a diagnosis of chronic pain. The project included  a review of 
medical records completed by prescribing providers (MD, DO, PA, NP).Male and female 
patients were identified to include in the project using the Ninth revision of International 
Classification of Disease (ICD-9) diagnoses codes 338.2 (chronic pain), 338.21 (chronic 
pain due to trauma), and 338.29 (other chronic pain). Patients 44 years of age and 
younger or 55 years and older and diagnosed with other types of pain (such as back or 
neck pain) without a diagnosis code of chronic pain were excluded due to the needs 
assessment shows the greatness number of patients who presented to the clinic with the 
diagnosis of chronic pain fell between the ages of 45 to 54 years of age.  For the purpose 
of this project, prescribing providers’ progress notes in the electronic medical record 
(EMR) of patients that meet inclusion criteria were accessed by retrospective chart 
review. The number of records accessed was determined by the number of patients that 
may present for services during the data abstracting time period.  
Design 
The design of the project is descriptive. This project consisted of a retrospective 
chart review of prescribers’ documentation in the medical record to determine if the 
27 
 
 
PDMP was accessed and if evidence-based protocols were used when prescribing opioid 
pain medication to patients diagnosed with chronic pain.  
Procedures 
After obtaining USM IRB approval, a systematic retrospective medical record 
chart review was conducted to determine whether prescribing providers access the PDMP 
and use evidence-based guidelines prior to prescribing opioid pain medications to 
patients with complaints of chronic pain. The project director was a full-time prescriber, 
family nurse practitioner (FNP), at the community health primary care clinic.  Prior to 
conducting the retrospective chart review, informed consent was obtained by the Project 
Director (PD) from the provider participants to access and report documentation of 
evidence-based guidelines in records of patients seen with a diagnosis of chronic pain. 
After the PD obtained provider consent, the trained data abstractor  conducted  a 
retrospective chart review to determine whether prescribing providers access the PDMP 
and use evidence-based guidelines to minimize a patient’s risk for prescription opioid 
pain medication misuse in a community health primary care setting.  The data abstractor 
is a full-time prescriber, family nurse practitioner (FNP), at the community health 
primary care clinic. 
Electronic medical records (EMR) were accessed by the trained data abstractor 
who is employed at the community health primary care clinic. Training and education 
was provided by the PD on documentation that should be included in the medical record 
when prescribing opioids.  Records were abstracted from the selected timeframe of 
October 1 thru December 31 2014 of patients who presented to the clinic and meet 
inclusion criteria for data collection.  Subject selection was based on patient’s age 45 to 
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54 years with the diagnosis of chronic pain using the ICD-9 diagnoses codes of 338.2, 
338.21, and 338.19 during the three month timeframe (Centers for Medicaid and 
Medicare Services [CMS], n.d.).  
EMR access. After logging in to the EMR using a unique protected password, the 
trained data abstractor, an employee of the clinic, generated a report of patients that met 
inclusion criteria. The report query was generated by going to the reports menu. Once the 
reports menu was accessed, the data abstractor entered the reporting criteria, (the age of 
the patients [age 45-54 years], the reporting period [October 1 2014 thru December 31, 
2014], and the diagnoses codes [338.2, 338.21, 338.19] to be associated with each record 
as described above). When the criteria were entered the generate report tab was used to 
create a list of patient records that meet the given criteria. The report, although generated 
at the main clinic, provided information on patients from all three clinics. Once the report 
was generated, the trained data abstractor printed the report to identify records that were 
accessed for data extraction. Each patient on the list was assigned a unique identification 
(ID) number. The identification number was coded on the data collection form (Appendix 
B). The report with the names of patients that meet inclusion criteria and the data 
collection form with ID numbers will be kept in a lock drawer in the data abstractor’s 
office at the clinic.  During data collection, the patient’s medical record was accessed 
from the list of patients that meet inclusion criteria by entering the patients’ name into the 
EMR.  
 EMR documentation. Once the progress note in the patient’s record was accessed 
the most recent visit/encounter was reviewed for extraction of whether evidence-based 
guidelines were utilized including accessing the PDMP. The progress note is the only 
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section of the EMR that was evaluated for documentation of accessing the PDMP and 
whether evidence-based guidelines were utilized.  Using a data extraction tool (Appendix 
F) with the patient ID number that matches the ID number on the query report, the most 
recent visit/encounter’s progress note was assessed for the type of prescribing provider 
(MD, DO, PA, NP) that delivered health care to the patient, documentation of whether 
the prescriber obtained a complete history and physical, accessed the PDMP, obtained a 
urine drug screen, and had the patient sign an informed consent/patient agreement. The 
nature of pain, intensity of pain, past treatment for pain, co-existing medical conditions, 
effect of pain on physical functioning, and past history of substance abuse were evaluated 
in the history and physical documentation. The informed consent was evaluated to 
determine if patient education on risk and benefits of use, an agreement for use of opioids 
and reason(s) for discontinued prescribing of opioids were documented. The progress 
note was reviewed to evaluate whether the risk of misuse is minimized as evidence by 
prescribing providers documentation of whether an opioid pain medication was 
prescribed; an opioid pain medication dose was lowered; a referral to any other 
disciplines such as physical therapy or pain management was generated; goals are clearly 
identified in the medical record; and education was provided. 
Data collection. No identifying information will be recorded on the data 
collection form. Confidentiality of the data were maintained by the utilization of 
identification numbers (ID) instead of names. Each question was numbered with a 
dichotomous response. A “yes” answer will be coded as “1”, a “no” answer will be coded 
as “2”.  Once the information was collected on the data collection tool, the results were 
documented in an excel spread sheet using codes for each variable. Review and analysis 
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of de-identified existing data were performed using SPSS procedure crosstabs which is a 
chi square statistical analysis program. Data were stored under double locks in the office 
of the trained data abstractor in the clinic by which only the data abstractor had access. 
Ethical protection of human subjects. The project consisted of a retrospective 
chart review with no identifying information. Data were extracted by the data abstractor 
directly from the progress note in the EMR and no records were printed or copied. Data 
were recorded and summarized by the trained data collector so that subjects cannot be 
identified, directly, or through identifiers linked to the subjects. To ensure confidentiality 
and anonymity, subjects’ information was protected through the use of codes assigned by 
the data abstractor on a data collection form. Data on the generated report and data 
collection tool were stored under double locks in the office of the trained data abstractor 
in the clinic by which only the data abstractor had access.  The data collection tools were 
placed in an envelope by the data abstractor and given to the project director (PD) for 
analysis and completion of the project. Data entered on the data collection tool did not 
contain any identifying information. Information on the data collection tool was entered 
into an Excel spreadsheet by the PD in order to maintain confidentiality.  Data were 
stored on a password protected computer. Confidentiality was protected by placing the 
data collection tools in a locked file box that was be kept in the office of the PD and only 
the PD had access to the locked file box and drawer.  
 There were minimal risks of harm to subjects associated with this project. The 
project consisted of a retrospective chart review. The primary subjects are the health care 
providers, and data on documentation in the patient's EMR was reported in aggregate, no 
single person was identified. Data are anonymous via de-identification and was protected 
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using coding, and cannot be associated with individual subjects; therefore, loss of privacy 
and breach of confidentiality was not a risk. Although the project director knows who the 
providers are, the association of providers to which data were not accessible. Providers 
who agreed to participate may fear occupational consequences if they do not participate, 
but were assured of no consequences for not participating on the consent given prior to 
participation.   Benefits of this project are to improve evidence-based prescribing 
practices among healthcare providers and minimize opioid pain medication misuse 
among patients with chronic pain in a primary care setting.  
Data Analysis 
 Data were retrieved through a review of the medical records and extracted using a 
collection tool created to look at indicators of whether evidence-based protocols are 
present in the documentation. Dichotomous variables were collected and coded.  
Information collected with the data extraction tool was entered into an Excel spreadsheet 
using a unique index identifier to prevent duplication. The answer to each question was 
coded and entered into the spreadsheet.  Once the data collection was completed, the 
information was analyzed using SPSS procedure crosstabs which is a chi square to 
determine if prescribers are utilizing evidence-based guidelines to minimize risk of 
opioid pain medication misuse.  Chi square testing was utilized due to the dichotomous 
“yes” or “no” answers to the data collection tool to count the categories of responses.   
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CHAPTER III 
RESULTS 
The purpose of this doctoral capstone project was to determine if providers are 
accessing the PDMP and utilizing evidence-based guidelines to minimize opioid pain 
medications misuse among patients with chronic pain in a primary care setting. Seven 
(N=7) records were identified which met inclusion criteria for the project, patients who 
presented to the primary care clinic with the diagnosis codes of 338.2 (chronic pain), 
338.21 (chronic pain due to trauma), and 338.29 (other chronic pain) and age range 
between the ages of 45-54 years.  Seven providers (3 physicians, 3 nurse practitioners, 
and 1 physician assistant) consented to have medical records reviewed of patients that 
were seen that met inclusion criteria. All records abstracted were records that were 
documented by the 3 nurse practitioners. The physician assistant and physicians did not 
have any records that met the criteria for inclusion in the study.  
 The most recent visit/encounter’s progress note was assessed for the type of 
prescribing provider (MD, DO, PA, NP) that delivered health care to the patient, 
documentation of whether the prescriber obtained a complete history and physical, 
accessed the PDMP, obtained a urine drug screen, and had the patient sign an informed 
consent/patient agreement. The history and physical documentation includes the nature of 
pain, intensity of pain, past treatment for pain, co-existing medical conditions, effect of 
pain on physical functioning, and past history of substance abuse. The informed 
consent/patient agreement consists of patient education on risk and benefits of use, an 
agreement for use of opioids and reason(s) for discontinued prescribing of opioids. The 
progress note was also reviewed to evaluate whether the risk of misuse is minimized as 
evidence by prescribing providers documentation of whether an opioid pain medication 
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was prescribed; an opioid pain medication dose was lowered; a referral to any other 
disciplines such as physical therapy or pain management was generated; goals are clearly 
identified in the medical record; and education was provided. The data collection was 
completed and analyzed using chi square distribution.  
 History and Physical. All (N=7; 100%) of the charts had a history and physical 
documented by the providers in the medical record that included the nature of pain, 
intensity of pain, past treatments of pain, co-existing, and effects of pain on physical 
functioning .  As seen in table 1 below the majority of the records (n=6; 87.5%) had no 
documentation of past substance abuse.   
Table 1  
History and physical 
Variables 
 
Frequency Percent 
History and 
Physical 
Yes 7 100.0 
    
Nature of 
pain 
Yes 7 100.0 
    
Intensity of 
pain 
Yes 7 100.0 
Past pain 
treatments 
Yes 7 100.0 
Co-existing 
conditions 
Yes 7 100.0 
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Table 1 (continued). 
Variables 
 
Frequency Percent 
 
Effect of 
pain on 
physical 
functioning 
Yes 7 100.0 
Past history 
of substance 
abuse 
Yes 
No 
1 
6 
14.3 
85.7 
 
 Prescription Drug Monitoring Program. Documentation of accessing the 
Prescription Drug Monitoring Program (PDMP) prior to prescribing opioid pain 
medication was not documented by providers most (n=5; 71.4%) of the time.  
 Evidence-Based Guidelines. Table 2 shows the results of whether evidence-based 
guidelines were followed to minimize risk for opioid pain medication misuse. All (N=7; 
100%) of the charts were missing documentation of obtaining a urine drug screen prior to 
prescribing an opioid pain medication and more than half (n=4; 57.1%) of the charts were 
missing documentation of an informed consent/patient agreement.  When patients 
presented to the clinic with complaints of chronic pain, patients were prescribed an opioid 
pain medication by the provider less than half (n=3; 42.9%) of the time and if prescribed 
(N=3; 100%) the dose was not lowered. The majority of the charts reviewed indicated 
that patients were referred to another discipline (n=4; 57.1%); goals were identified to 
improve functioning (n=5; 71.4%), and education on safety (n=4; 57.1%) was provided.  
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Table 2 
Evidence-based guidelines 
Variables Frequency Percent 
PDMP accessed Yes 2 28.6 
No 5 71.4 
 
   
Informed consent/ 
Patient Agreement 
Yes 
No 
3 
4 
42.9 
57.1 
 
   
Urine drug screen No 7 100.0 
 
   
Was an opioid prescribed? Yes 
No 
3 
4 
42.9 
57.1 
 
   
Was opioid dose lowered? No 7 100.0 
 
   
Was patient referred to 
other discipline? 
Yes 
No 
4 
3 
57.1 
42.9 
 
   
Were goals clearly 
identified? 
Yes 
No 
5 
2 
71.4 
28.6 
Was education 
documented on safety? 
Yes 
No 
4 
3 
57.1 
42.9 
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CHAPTER IV 
DISCUSSION 
 The misuse of opioid pain medications has become an epidemic in the United 
States. Federal and state governing bodies have implemented evidenced-based guidelines 
which include accessing the Prescription Drug Monitoring Programs (PDMP) to aide in 
minimizing opioid pain medication misuse. This capstone project was implemented to 
evaluate the use of evidence-based guidelines by providers in a primary care setting. 
While the data shows overall implementation of the guidelines, there is still room for 
improvement. Although providers are indeed showing great efforts in thoroughly 
documenting the history and physicals, documentation of the past history of drug abuse 
has not shown to be an area where the prescribers have documented consistently.  The 
past history of substance abuse should be clearly documented as part of the medical 
records prior to prescribing opioid pain medications (FSMB, 2004).  A patient’s history 
of substance abuse should aide a prescriber in recognizing whether a patient is at risk of 
misuse of opioid pain medications.  Accessing the PDMP is an area where it shows the 
prescribers are not consistent. The analysis shows that the PDMP was only accessed and 
documented 28.6% of the time. When prescribing opioid pain medications, the PDMP 
should be accessed to aide in recognizing misuse.   
 While a history of drug abuse was not consistently assessed when conducting a 
medical history, a urine drug screen was not documented as being performed prior to 
prescribing an opioid pain medication in any of the medical records reviewed.  Consistent 
documentation of evidence-based guidelines was lacking in the chart review. The results 
of whether there was an informed consent/patient agreement which gives the patient 
education on risks, benefits, agreements for use, and reasons why the  
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prescriptions may be terminated, according to the data analysis, was documented 42.9% 
of the time.  According to evidence-based guidelines, an informed consent should be 
signed by the patient and provider when prescribing opioid pain medications.  
 Other the other hand, the majority of the charts reviewed showed documentation 
of some of the evidence-based guidelines. Patients were referred to another discipline. 
Referring patients to other disciplines such as physical therapy and pain management is 
one step that will assist in minimizing the patient’s risk for misuse of opioid pain 
medication. According to national guidelines from the Federation of State Medical 
Boards, goals for functioning levels should be clearly identified when prescribing opioid 
pain medications (FSMB, 2004).  The study shows that in 71.4% of the medical records 
were identified to have documentation of goals to improve functioning. Education on 
safety was identified in 57.1% of the medical records abstracted during this project.  
When prescribing opioid pain medications, each patient should be educated on the risks 
of taking opioid pain medications for extended periods of time and given alternative 
treatments and timeframes of weaning off the medications.  
Prescribers should also attempt to lower the dosages of opioid pain medications of 
patients with complaints of chronic pain. When patients presented to the clinic with 
complaints of chronic pain, 42.9% of the time they are prescribed an opioid pain 
medication and the dose was not lowered when prescribing opioids. Although the 
statistics may seem a little alarming, there were some limitations to the project.   
Limitations. Some of the limitations noted for this study include the small sample 
size and the staff turnover rate.  Although 13 providers were educated, only seven 
providers consented to have their medical records reviewed.  During the project the clinic 
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had resignations from two prescribers.  With the decrease in the prescribing staff during 
the project, there is the potential that fewer patients were seen during the three month 
time frame for the project.  These changes may have played a part in the small sample 
size.  The small sample size is also hypothesized to have contributed to possible 
procedures for coding the diagnosis. The diagnoses codes for chronic pain 338.2, chronic 
pain due to trauma 338.21, or other trauma 338.29 were identified for this project. It is 
unknown if other pain diagnoses codes were used by providers that apply to the particular 
areas of the body such as back pain or leg pain.  Other limitations to the study include the 
cost of urine drug screening, especially in a community health clinic.  Urine drug testing 
for screening purposes may not be covered by insurance companies and providers may be 
reluctant to order urine drug screens due to the cost of testing.  Prior to beginning the 
capstone project, discussions were held with the prescribers regarding the proposed goals 
of the project and the idea of medical records review. This may have alerted the 
prescribers to the possibility of their records under review and increased compliance with 
utilizing the evidence-based protocols. The increase in compliance with utilizing 
evidence-base protocols prior to prescribing an opioid pain medication was a goal for this 
project overall.  
Framework.  Using the Plan-Do-Check-Act for continuous quality improvements 
showed to be beneficial in guiding this study.  Deming’s theory of using statistical data to 
show root causes to problems and create a solution helped to guide this project in 
showing whether the providers were utilizing evidence-based guidelines to minimize the 
risk of opioid misuse.  The theory of constantly and forever improving systems shows us 
that the improvements needed do not stop at this project.  The evaluation plan proves 
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there is still work to be done.  This is an ever evolving quality improvement plan to look 
at improving patient outcomes and also decreasing healthcare as well as societal costs.  
Implications for practice. The implications for future practice are to increase 
providers’ awareness of evidence-based guidelines when prescribing opioid pain 
medications.  The results of this project will be shared with the key stakeholders of the 
primary care community health clinic where this project was performed with suggestions 
for implementing evidence-based guidelines for proper prescription opioid pain 
medication prescribing. Implementation of evidence-based guidelines will be imperative 
in the fight for minimizing risk of misuse of opioid pain medications.  As prescribers are 
educated and evidence-based guidelines are implemented, the risks of over-prescribing or 
improper prescribing should show a decrease in misuse of opioid pain medications.   
Recommendations for future research.  Continuous process improvements in the 
area of evidence-based protocols to minimize opioid pain medication should be in the 
forefront of projects considered for future practice changes.  Further studies should be 
completed on whether proper prescribing habits actually decrease the misuse of opioid 
pain medications. Further evaluations should be performed to assess the barriers to 
utilizing evidence-based guidelines.  The type of funding to assist with the effort to 
combat opioid pain medication misuse is another area that should be further explored.  
Insurance companies may not pay for urine drug screening in the clinic setting.  Patients 
may not want to pay to have a urine drug screening performed.  Screening could become 
a burden on the community health care clinic’s budget.  As the problem of opioid pain 
medication misuse has steadily increased over the past decades, DNP prepared nurse 
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practitioners are equipped to research the evidence and implement protocols to minimize 
risk and change practices.  
Conclusions. This doctoral capstone project shows that the providers are 
documenting components of the history and physical when patients present to a primary 
care clinic with complaints of chronic pain. Past history of drug abuse and ordering urine 
drug screens are evidence-based practice recommendations where prescribers have not 
documented consistently.  Accessing the PDMP is another area where it shows the 
prescribers are not consistently documenting. Implementation of evidence-based 
guidelines will be imperative in the fight to minimize risk of misuse of opioid pain 
medications among patients with chronic pain in the primary care setting.  Improving 
prescribing habits to minimize prescription opioid drug misuse will show an 
improvement in patient outcomes and lessen the societal burden of prescription drug 
misuse in Mississippi and nationally.  The DNP prepared advanced practice nurses will 
be prepared to evaluate and implement ongoing process improvements to further improve 
patient outcomes in a system that is associating reimbursement with the quality of care 
provided, while also working to decrease the financial burden on the current healthcare 
system.  
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APPENDIX A 
 
LITERATURE REVIEW TABLE 
 
Authors date Study type Sample Data collection Key findings 
Worley 
(2012) 
Literature 
Review 
Eleven peer 
reviewed 
research 
articles were 
used.  
A critical 
analysis of the 
articles  
PDMP’s are 
useful and 
necessary to 
curb 
prescription 
drug abuse and 
diversion. 
More research 
is needed to 
determine the 
frequency and 
barriers to use 
of PDMP’s.  
Culberson, 
Ziska (2008) 
Not a research 
article 
Elderly Literature 
review 
Elderly are at 
increased risk 
of abuse of 
certain 
medications.  
The 
development 
and validation 
of screening 
instruments 
and treatment 
guidelines for 
prescription 
drug abuse in 
the elderly are 
needed.  
Dunn, et.al. 
(2010) 
Cohort study 9940 patients 
who received 3 
or more opioid 
prescriptions 
within 90 days 
for chronic 
non-cancer 
pain 
Pharmacy data 
and medical 
records review 
Overdose 
occurs at 
increased rates 
in patients 
prescribed 
opioids for 
non-cancer 
chronic pain. 
PDMP Center 
of Excellence 
 Review of over 
60 resources 
and data 
Survey of 60 
references that 
includes 
PDMPs are 
effective in 
improving 
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Authors date Study type Sample Data collection Key findings 
complied into a 
report or 
briefing 
research 
studies, 
evaluations, 
surveys, 
reports, and 
data  
clinical 
decision 
making and 
improving 
patient 
outcomes. 
PDMP will 
become more 
effective as 
prescribers 
continue to use 
evidence-based 
best practices 
Reigler, et.al. Observational 
study 
Observed calls 
to a poison 
control center 
and admissions 
to a opioid 
treatment 
center 
Quarterly 
surveillance 
data 
Shows the 
increase of 
intentional 
exposures to 
opioids and the 
increase of 
admission to 
opioid 
treatment 
centers to be 
much less in 
states where 
PDMPs had 
been 
implemented.  
Center for 
Disease 
Control and 
Prevention 
Evidence-based 
guidelines 
 A review of 
evidence based 
guidelines 
Common 
elements of 
different 
evidence-based 
guidelines 
Federation of 
States 
Medical 
Boards (2004) 
Evidence-based 
Guidelines 
  A policy for 
use of 
controlled 
substances 
when treating 
chronic pain 
SM Fishman 
(2012) 
Evidence-based 
guidelines 
  A clinical 
guideline for 
responsible 
opioid 
prescribing  
WM Hooten A systematic  A literature Guidelines 
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Authors date Study type Sample Data collection Key findings 
(2013) review of 
literature  
search using 
PubMed and 
Cochrane 
databases 
were developed 
to help primary 
care providers 
better diagnose 
and treat pain.  
Nuckols. 
Et.al. (2014) 
A critical 
appraisal of 
evidence-based 
guidelines 
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APPENDIX B 
 
DNP ESSENTIALS  
 
Essential DNP Capstone 
Scientific underpinning for practice This project integrated nursing science 
using analytical and organizational as the 
highest level of nursing science with the 
evaluation and implementation of 
evidence-based guidelines to minimize 
risk of prescription opioid pain 
medications.  Also evaluated and 
implemented new practice approaches to 
prescribing opioid pain medications to 
improve outcomes of the patients.  
 
Organizational and systems leadership for 
quality improvement and systems thinking 
Implementing this project used advances 
processes to lead quality improvements 
and patient safety initiatives in the clinical 
setting.  Employed health policy to 
develop and implement effective plans for 
system-wide practice by implementing 
evidence-based guidelines to minimize the 
risk of prescription opioid pain medication 
misuse in a primary care clinic.  
 
Clinical scholarship and analytical 
methods for evidence-based practice 
Analytical methods to critically appraise 
existing literature and other evidence was 
used to determine and implement the best 
practice for prescribing opioid pain 
medications. Quality improvement 
methodologies were implemented to 
promote safe, effective, and patient-
centered care for prescribing of opioid 
pain medications. Practice guidelines from 
relevant findings were implemented to 
improve practice.  
 
Information system/technology for the 
improvement and transformation of health 
Demonstrated the conceptual ability and 
technical skills to develop and execute 
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care and evaluation plan involving data 
extraction from practice information 
systems and databases. Provided 
leadership in the evaluation of prescribing 
habits of providers in the primary care 
clinic relating to the use of information 
technology and patient care technology. 
 
Health care policy for advocacy in health 
care 
Critically analyzed health policy related to 
prescription opioid pain medication 
misuse. Demonstrated leadership in the 
implementation of states and federal 
guidelines for opioid pain medication 
prescribing. Educated others on regarding 
health policy and patient care outcomes.  
 
Interprofessional collaboration for 
improving patient population and 
population outcomes 
Employed effective collaborative skills in 
the implementation of practice guidelines. 
Employed leadership skills with 
interprofessional teams to create change in 
the health care delivery of patients who 
present to the primary care clinic with 
complaints of chronic pain. 
 
Clinical prevention and population health 
for improving the nation’s health 
Analyzed epidemiological, biostatistical 
and other scientific data related to 
population health of patients who present 
to the community health primary health 
clinic with the diagnosis of chronic pain. 
Synthesized concepts related to 
population health in implementing and 
evaluating interventions to address health 
promotions to minimize risk of 
prescription opioid pain medication 
misuse in the primary care setting.  
 
Advanced nursing practice Conducted a comprehensive and 
systematic assessment of prescribing 
habits of the providers in a community 
health primary care clinic. Demonstrated 
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advanced levels of clinical judgment, 
systems thinking and evaluating evidence-
based care to improve patient outcomes. 
Educated prescribers in evidence-based 
guidelines to minimize risk of prescription 
opioid pain medication misuse.  
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LOGIC MODEL 
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APPENDIX D 
 
IRB APPROVAL LETTER 
 
  
  INSTITUTIONAL REVIEW BOARD  
  118 College Drive #5147 | Hattiesburg, MS  39406-0001  
  Phone:  601.266.5997 | Fax:  601.266.4377 | www.usm.edu/research/institutional.review.board  
   
NOTICE OF COMMITTEE ACTION  
  
The project has been reviewed by The University of Southern Mississippi Institutional Review 
Board in accordance with Federal Drug Administration regulations (21 CFR 26, 111), Department 
of Health and Human Services (45 CFR Part 46), and university guidelines to ensure adherence to 
the following criteria:  
• The risks to subjects are minimized.  
• The risks to subjects are reasonable in relation to the anticipated benefits.  
• The selection of subjects is equitable.  
• Informed consent is adequate and appropriately documented.  
• Where appropriate, the research plan makes adequate provisions for monitoring the data 
collected to ensure the safety of the subjects.  
• Where appropriate, there are adequate provisions to protect the privacy of subjects and to 
maintain the confidentiality of all data.  
• Appropriate additional safeguards have been included to protect vulnerable subjects.  
• Any unanticipated, serious, or continuing problems encountered regarding risks to subjects 
must be reported immediately, but not later than 10 days following the event.  This should 
be reported to the IRB Office via the “Adverse Effect Report Form”.  
• If approved, the maximum period of approval is limited to twelve months.  
      Projects that exceed this period must submit an application for renewal or continuation.  
  
PROTOCOL NUMBER: 15012801         
PROJECT TITLE:  Evidence-Based Strategies to Minimize Risk of Opioid Pain Medication Misuse  
Among Patients with Chronic Pain in a Primary Care Setting     
PROJECT TYPE: New Project     
RESEARCHER(S):  Carolyn Coleman  
COLLEGE/DIVISION:  College of Nursing  
DEPARTMENT: Systems Leadership and Health Outcomes  
FUNDING AGENCY/SPONSOR: N/A  
IRB COMMITTEE ACTION:  Expedited Review Approval 
PERIOD OF APPROVAL: 01/28/2015 to 01/27/2016  
Lawrence A. Hosman, Ph.D.            
Institutional Review Board    
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  APPENDIX E 
LETTER OF SUPPORT 
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APPENDIX F 
 
DATA COLLECTION TOOL 
 
Identification Number ________________  
 
 
Yes No 
History and Physical   
Nature of pain   
Intensity of pain   
Past pain  treatments   
Co-existing conditions   
Effect of pain on physical functioning   
Past history of substance abuse   
PDMP accessed   
Informed Consent/Patient Agreement   
Urine Drug Screen   
Was an opioid prescribed?   
Was opioid dose lower?   
Was patient referred to other discipline?   
Were goals clearly identified?   
Was education documented on safety?   
PROVIDER   
MD contract    
MD full-time   
PA contract     
PA full-time   
NP contract    
NP full-time    
 
 
 
 
_____________________________ 
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